Mucotreis (Carbocisteine)

Carbocisteine acts as a mucolytic agent to improve clearance of thick respiratory secretions.

• Chronic bronchitis: helps thin mucus, facilitating expectoration and reducing cough frequency.
• Chronic obstructive pulmonary disease (COPD): eases airway obstruction by decreasing mucus viscosity.
• Cystic fibrosis: assists in clearing thick pulmonary secretions, supporting airway hygiene.

• Carbocisteine reduces mucus viscosity by breaking disulfide bonds within mucopolysaccharide chains, altering the structure of glycoproteins in the mucus gel. This modification lowers the elastic and adhesive properties of mucus, allowing ciliary action and cough to clear secretions more effectively from the respiratory tract.

Carbocisteine is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Nausea: mild stomach upset after oral intake.
• Diarrhea: loose stools, usually transient.
• Abdominal pain: cramping or discomfort in the stomach area.
• Dyspepsia: indigestion or heartburn.
• Headache: mild to moderate pain.
• Skin rash: mild erythema or itching.

Serious or Rare Side Effects

• Allergic reaction: swelling of face, lips, or throat, requiring immediate medical attention.
• Severe gastrointestinal bleeding: uncommon but serious, presenting with blood in stool.
• Hepatic dysfunction: rare elevation of liver enzymes.
• Hematologic abnormalities: rare cases of leukopenia or thrombocytopenia.
• Anaphylaxis: life‑threatening systemic reaction, extremely rare.

When using Carbocisteine, consider the following precautions.

• Pregnancy: consult a healthcare professional before use; safety data are limited.
• Breastfeeding: discuss potential risks with a physician, as drug may pass into milk.
• Renal impairment: dose adjustment may be needed; monitor kidney function.
• Hepatic disease: use with caution; monitor liver enzymes.
• Concomitant mucolytics: avoid simultaneous use of multiple mucolytic agents to prevent excess thinning of mucus.
• Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture and direct sunlight.

Carbocisteine may interact with other medications; monitor accordingly.

Major Interactions (Avoid)

• Antitussives (e.g., codeine): may counteract mucolytic effect, reducing clearance.
• Bronchodilators with strong anticholinergic activity: potential additive dryness of airways.

Moderate Interactions (Monitor Closely)

• Antibiotics (e.g., macrolides): may increase risk of gastrointestinal upset.
• Anticoagulants: rare reports of enhanced bleeding risk; monitor coagulation parameters.
• Other mucolytics (e.g., N‑acetylcysteine): combined use may cause excessive mucus thinning.
• Herbal supplements (e.g., guaifenesin): monitor for additive mucolytic effect.